These benefits, along with a previous report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two guidance the notion of focusing on ACKR3 as a novel solution to modulate the opioid method, which could open new therapeutic avenues for opioid-connected disorders.The similarity in between a set of prescrip